Related articles

• Drug resistance mechanisms in cancers: Execution of pro-survival strategies
  2024, 38(2): 95-121. DOI: 10.7555/JBR.37.20230248
• Insulin receptor is implicated in triple-negative breast cancer by decreasing cell mobility
  2021, 35(3): 189-196. DOI: 10.7555/JBR.34.20200082
• RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer
  2020, 34(2): 129-138. DOI: 10.7555/JBR.34.20190111
• Sonic Hedgehog stimulates migration of MCF-7 breast cancer cells through Rac1
  2019, 33(5): 297-307. DOI: 10.7555/JBR.32.20180100
• Effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki67 in Chinese breast cancer patients: A retrospective study of 525 patients
  2018, 32(3): 191-197. DOI: 10.7555/JBR.32.20170059
• Association of three single nucleotide polymorphisms of ESR1 with breast cancer susceptibility: a meta-analysis
  2017, 31(3): 213-225. DOI: 10.7555/JBR.31.20160087
• Osthole inhibits proliferation of human breast cancer cells by inducing cell cycle arrest and apoptosis
  2015, 29(2): 132-138. DOI: 10.7555/JBR.27.20120115
• Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients
  2013, 27(6): 478-485. DOI: 10.7555/JBR.27.20130021
• Effect of EME1 exon variant Ile350Thr on risk and early onset of breast cancer in southern Chinese women
  2013, 27(3): 193-201. DOI: 10.7555/JBR.27.20130013
• STAT3 mediates resistance of CD44+CD24-/low breast cancer stem cells to tamoxifen in vitro
  2012, 26(5): 325-335. DOI: 10.7555/JBR.26.20110050